ASK REDCHAT ANYTHING ABOUT FORTE BIOSCIENCES INC.
Forte Biosciences Inc. (NASDAQ: FBRX)
Listen to this Section
$16.17
-0.5240
(
-3.14% )
196.1K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| FB102DetailsGraft-versus-host disease |
Phase 1 |
Market Data
|
| Open |
$16.17 |
| Previous Close |
$16.69 |
| Volume |
196.1K |
| Market Cap |
$348.14M |
| Day Range |
$16.00 - $16.66 |
| 52 Week Range |
$9.10 - $35.80 |
| Shares Outstanding |
20.48M |
| Change % |
-3.14% |
| Net Change |
▼ -0.5240 |
| Insider Ownership |
-0.03% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2020 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-1,867,963.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-11-22 |
Buy |
22514.00 |
Riley Antony A |
| 2024-07-03 |
Sale |
-31250.00 |
Wagner Paul A. |
| 2024-07-03 |
Sale |
-9375.00 |
Riley Antony A |
| 2024-04-02 |
Sale |
-9375.00 |
Riley Antony A |
| 2024-04-02 |
Sale |
-31250.00 |
Wagner Paul A. |
| 2024-03-25 |
Sale |
-1100000.00 |
Wagner Paul A. |
| 2024-03-25 |
Sale |
-350000.00 |
Riley Antony A |
| 2024-03-25 |
Sale |
-175000.00 |
FINCK BARBARA K |
| 2024-01-03 |
Sale |
-31250.00 |
Wagner Paul A. |
| 2024-01-03 |
Sale |
-7500.00 |
Chen Hubert C |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| schedule |
Other |
1 |
Nov 14, 2025 |
| schedule |
Other |
2 |
Nov 14, 2025 |
| 10-q |
Quarterly Reports |
61 |
Nov 14, 2025 |
| 8-k |
8K-related |
14 |
Nov 14, 2025 |
| schedule |
Other |
5 |
Oct 07, 2025 |
| 4 |
Insider transactions |
1 |
Oct 02, 2025 |
| 4 |
Insider transactions |
1 |
Oct 02, 2025 |
| 8-k |
8K-related |
83 |
Aug 14, 2025 |
| 10-q |
Quarterly Reports |
64 |
Aug 14, 2025 |
| 4 |
Insider transactions |
1 |
Jul 03, 2025 |